...
首页> 外文期刊>BMC Neurology >Scepter dual‐lumen balloon catheter for Onyx embolization for dural arteriovenous fistula
【24h】

Scepter dual‐lumen balloon catheter for Onyx embolization for dural arteriovenous fistula

机译:用于多云动脉瘘的Onyx栓塞的Scepter双腔球囊导管

获取原文

摘要

Abstract Background This study aimed to evaluate the efficacy and safety of Scepter dual-lumen balloon catheter for transarterial Onyx embolization of dural arteriovenous fistula (DAVF). Methods Transarterial Onyx embolization using a Scepter dual-lumen balloon catheter (Scepter-assisted Onyx embolization) for DAVF was attempted in a total of 35 patients (mean age, 52.5 years; M:F?=?24:11) between October 2012 and December 2018. The results of Scepter-assisted Onyx embolization were evaluated with respect to total procedural and Onyx injection times, the types and number of feeders requiring embolization, angiographic and clinical outcomes, and treatment-related complications. Results Initial presentations were non-hemorrhagic neurological deficits in 10, intracranial hemorrhage in 8, seizure in 7, headache in 7, and intractable tinnitus in 3. All DAVF were aggressive type (Borden type 2, 14.3?%; type 3, 85.7?%). Scepter-assisted Onyx embolization resulted in immediately complete occlusion in 33 patients (94.3?%) and near complete occlusion in 2 patients. Middle meningeal artery (51.4?%) was the most commonly used for Scepter-assisted technique, followed by occipital artery (42.9?%), ascending pharyngeal artery (2.9?%) and superficial temporal artery (2.9?%). There was no difference in complete occlusion rate between middle meningeal artery and the other arteries (94.4?% versus 94.1?%). The median number of total feeders embolized was 1 (range, 1–3). The median total procedural time was 45 minutes (range, 21 minutes – 127 minutes) and the median Onyx injection time was 11 minutes (range, 3 minutes – 25 minutes). All patients recovered completely (n?=?31) or partially (n?=?4) from presenting symptoms. Treatment-related complications occurred in 2 patients, of whom one had a permanent morbidity (2.8?%, ipsilateral facial nerve palsy). No patient showed a recurrence on follow-up imaging (median, 15 months; range, 3–56 months). Conclusions Scepter-assisted transarterial Onyx embolization showed a very high complete occlusion rate with a low morbidity and no recurrence in aggressive type DAVF. Scepter dual-lumen balloon catheter seems to be a useful tool for transarterial Onyx embolization of DAVF.
机译:摘要背景本研究旨在评估索佩特双腔气球导管用于多云动静脉瘘(DAVF)ratronterial on型腐蚀的功效和安全性。方法使用Scepter双腔球囊导管ryarterial Onyx栓塞(Scepter辅助Onyx栓塞),总共35例患者(平均年龄,52.5岁; M:F?=?24:11)和2012年间2018年12月。关于总程序和Onyx注射时间,需要栓塞,血管造影和临床结果以及治疗相关并发症的饲养者的类型和数量评估了Scepter辅助癌症栓塞的结果。结果初步介绍是10,8,颅内出血8,7,7中的头痛7,犬耳廓,3.所有DAVF都是侵袭性的(2,14.3〜14.3型;型3,85.7? %)。 Scepter辅助的Onyx栓塞导致33例患者立即完全闭塞(94.3?%),在2名患者中接近完全闭塞。中脑动脉(51.4?%)是最常用的术辅助技术,其次是枕骨动脉(42.9〜%),上升咽动脉(2.9〜%)和浅表颞动脉(2.9?%)。中脑动脉和其他动脉之间完全闭塞率没有差异(94.4倍,与94.1%)。栓塞的总馈线的中位数为1(范围,1-3)。中位数总程序时间为45分钟(范围,21分钟 - 127分钟),中位数肉蛋白注射时间为11分钟(范围,3分钟 - 25分钟)。所有患者均完全恢复(n?= 31)或部分(n?=Δ4)呈现出症状。治疗相关的并发症发生在2名患者中,其中一个人具有永久性发病率(2.8?%,同侧面部神经麻痹)。没有患者在后续成像(中位数,15个月;范围,3-56个月)上没有患者复发。结论权杖辅助transarterial玛瑙栓塞表现出与低发病率非常高的完全闭塞率和进取型DAVF不再复发。 Scepter双腔球囊导管似乎是ratrarial onyx栓塞DAVF的有用工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号